Physician profile
Tracey Taylor
NPI 1437519618
$4,956.19
in general payments reported to CMS, 2019-2025
20 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $754 · 2022: $943 · 2023: $676 · 2024: $835 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,258.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,458.47 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,172.60 | 2021-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $553.13 | 2021-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $312.86 | 2021-2025 | Dupixent |
| Amgen INC. | $257.79 | 2021-2025 | Tezspire |
| Insmed, INC. | $250.85 | 2024-2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $210.48 | 2025 | Ohtuvayre |
| Genzyme Corporation | $209.15 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $135.83 | 2025 | Lumryz |
| Philips North America LLC | $106.47 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und, (8874) Incourage |
| Inspire Medical Systems, INC. | $101.81 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $44.92 | 2022-2023 | |
| Mylan Specialty L.P. | $23.45 | 2022 | |
| Inogen, INC. | $20.42 | 2022 | |
| Merck Sharp & Dohme LLC | $20.10 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.54 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.28 | 2022 | |
| Lilly USA, LLC | $14.71 | 2025 | Zepbound |
| 3b Medical, INC. | $12.50 | 2025 | Luna |
| Teva Pharmaceuticals USA, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.